The reviewed record of science sign in
Pith

arxiv: 2607.00147 · v1 · pith:JG2MVUFR · submitted 2026-06-30 · cs.AI

RareDxR1: Autonomous Medical Reasoning for Rare Disease Diagnosis Beyond Human Annotation

Deyang Jiang , Haoran Wu , Ziyi Wang , Yiming Rong , Yunlong Zhao , Ye Jin , Bo Xu This is my paper

Reviewed by Pith T0 review T1 audit T2 compute T3 formal T4 kernel 2026-07-02 19:19 UTCgrok-4.3pith:JG2MVUFRrecord.jsonopen to challenge →

classification cs.AI
keywords rare disease diagnosisend-to-end traininglarge language modelsmedical reasoningreinforcement learningautonomous learning
0
0 comments X

The pith

RareDxR1 diagnoses rare diseases end-to-end from unstructured clinical notes by internalizing knowledge through progressive training and reflection on failures.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper presents RareDxR1 as a large language model that performs rare disease differential diagnosis directly from patient symptoms in free-form notes. It replaces pipeline methods that extract phenotypes or retrieve from external sources with a training process that folds fragmented disease knowledge straight into the model parameters. The approach adds a sampling method that builds diagnostic chains by examining the model's own mistakes and a curriculum that escalates task difficulty, producing higher accuracy on benchmarks than prior systems.

Core claim

RareDxR1 shows that an end-to-end reasoning-centric model can internalize fragmented rare-disease knowledge into its parameters via progressive training that combines knowledge internalization with autonomous evolutionary learning, and that Reflection-Enhanced Reasoning Sampling can generate expert-level diagnostic trajectories by learning from failures without any human annotation, yielding state-of-the-art accuracy on open-domain rare disease diagnosis benchmarks.

What carries the argument

The progressive end-to-end training framework that pairs knowledge internalization with Reflection-Enhanced Reasoning Sampling (RERS) to synthesize diagnostic trajectories from model failures and dual-level curriculum reinforcement learning to master the task gradually.

If this is right

  • Diagnosis proceeds without predefined phenotype lists or closed decision sets.
  • Retrieval bottlenecks and information loss from ontologies are removed.
  • Diagnostic logic improves by reflecting on the model's own prior errors.
  • Mastery of rare-disease cases occurs through staged curriculum reinforcement.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same internalization process might transfer to other medical domains that require chaining many low-frequency facts from unstructured text.
  • Models built this way could update their diagnostic reach by further training rather than by expanding external knowledge bases.
  • Deployment would need checks on whether the internalized patterns hold for patients whose symptom descriptions differ markedly from the training distribution.

Load-bearing premise

Fragmented rare-disease knowledge can be internalized into the model's parameters without loss through progressive training, allowing accurate reasoning without external retrieval or structured ontologies.

What would settle it

A controlled test on rare diseases whose details were absent from the model's training data, measuring whether accuracy collapses relative to retrieval-based baselines when no external lookup is permitted.

Figures

Figures reproduced from arXiv: 2607.00147 by Bo Xu, Deyang Jiang, Haoran Wu, Ye Jin, Yiming Rong, Yunlong Zhao, Ziyi Wang.

Figure 1
Figure 1. Figure 1: Top-10 Recall across all rare disease categories in RareArena-Test. [PITH_FULL_IMAGE:figures/full_fig_p001_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: The two-stage training framework for constructing the RareDxR1 model. [PITH_FULL_IMAGE:figures/full_fig_p003_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Analysis of CRR Performance. Performance of our method as collaborators are added with or without retrieved knowledge. K = 1 represents the model’s self-refinement using retrieved knowledge. The most significant performance leap originates from our SFT stage, which demonstrates the critical importance of domain￾specific adaptation. Within this stage, the inclusion of data from our Reflection-Enhanced Reaso… view at source ↗
read the original abstract

Rare disease differential diagnosis is a critical yet arduous clinical task, requiring physicians to identify precise phenotypes from complex, unstructured patient symptoms and execute intricate reasoning within a vast search space. However, existing AI approaches typically rely on pipeline-based phenotype extraction or retrieval-augmented generation, which suffer from critical information loss due to predefined ontologies, retrieval bottlenecks, and a lack of diagnostic logic. To address these challenges, we introduce RareDxR1, an end-to-end reasoning-centric large language model designed for open-domain rare disease diagnosis directly from unstructured clinical notes. We design a progressive end-to-end training framework by synergizing knowledge internalization with autonomous evolutionary learning, thereby bypassing reliance on structured phenotypes and closed-set decision-making. To overcome the limitations of RAG and phenotype restriction, we enabled the deep internalization of fragmented rare-disease knowledge directly into the model's parameters. Moreover, to bridge the gap between model generation and expert reasoning, we propose Reflection-Enhanced Reasoning Sampling (RERS), a strategy that synthesizes expert-level diagnostic trajectories by learning from failures without human annotation. Additionally, we propose a dual-level curriculum reinforcement learning approach for gradually mastering rare disease diagnosis. Experimental results demonstrate that RareDxR1 achieves state-of-the-art accuracy across different benchmarks, marking a significant breakthrough in open-domain rare disease diagnosis. Our code and dataset will be publicly available.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

1 major / 0 minor

Summary. The manuscript introduces RareDxR1, an end-to-end reasoning-centric LLM for open-domain rare disease diagnosis directly from unstructured clinical notes. It proposes a progressive end-to-end training framework that combines knowledge internalization with autonomous evolutionary learning, Reflection-Enhanced Reasoning Sampling (RERS) to synthesize expert-level diagnostic trajectories by learning from failures without human annotation, and a dual-level curriculum reinforcement learning approach. The abstract claims that these components enable bypassing of ontologies and RAG limitations, resulting in state-of-the-art accuracy across benchmarks.

Significance. If the claimed results hold, the work would be significant for medical AI by demonstrating an annotation-free, retrieval-free approach to rare-disease reasoning that internalizes fragmented knowledge into model parameters. The RERS mechanism for autonomous trajectory synthesis and the curriculum RL strategy represent potentially generalizable ideas for improving LLM reasoning in data-scarce domains.

major comments (1)
  1. [Abstract] Abstract: the central claim that 'RareDxR1 achieves state-of-the-art accuracy across different benchmarks' is asserted without any metrics, baselines, dataset sizes, error bars, ablation studies, or benchmark definitions. This prevents evaluation of whether performance is independent of training choices or reduces to internal signals.

Simulated Author's Rebuttal

1 responses · 0 unresolved

We thank the referee for highlighting the need for greater specificity in the abstract. We address this point directly below and commit to revisions that improve clarity without altering the manuscript's core contributions.

read point-by-point responses

  1. Referee: [Abstract] Abstract: the central claim that 'RareDxR1 achieves state-of-the-art accuracy across different benchmarks' is asserted without any metrics, baselines, dataset sizes, error bars, ablation studies, or benchmark definitions. This prevents evaluation of whether performance is independent of training choices or reduces to internal signals.

    Authors: We agree that the abstract, due to its brevity, presents the SOTA claim without accompanying quantitative details. The full manuscript reports these elements in the Experiments section, including explicit benchmark definitions, dataset sizes, baseline comparisons (e.g., against RAG-based and phenotype-extraction methods), error bars from multiple runs, and ablation studies isolating the contributions of knowledge internalization, RERS, and curriculum RL. These ablations are designed to demonstrate that gains arise from the proposed reasoning mechanisms rather than training artifacts or internal signals alone. To directly address the concern, we will revise the abstract to include representative metrics (e.g., accuracy deltas and key baselines) and a brief note on the experimental controls, while preserving the word limit. revision: yes

Circularity Check

0 steps flagged

No circularity in derivation chain

full rationale

The abstract and description present a progressive end-to-end training framework, RERS sampling, and dual-level curriculum RL as novel components that internalize knowledge and achieve SOTA results. No equations, fitted parameters renamed as predictions, self-citations, or uniqueness theorems are quoted or referenced in the provided text. Claims rest on experimental results rather than any self-referential reduction by construction, making the chain self-contained against external benchmarks.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

Only abstract available; no explicit free parameters, axioms, or invented entities can be extracted. The central claim rests on unstated assumptions about successful knowledge internalization and the validity of self-generated reasoning trajectories.

pith-pipeline@v0.9.1-grok · 5783 in / 1149 out tokens · 19028 ms · 2026-07-02T19:19:32.577106+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

35 extracted references · 35 canonical work pages · 5 internal anchors

  1. [1]

    How many rare diseases are there?

    M. Haendel, N. Vasilevsky, D. Unni, C. Bologa, N. Harris, H. Rehm et al., “How many rare diseases are there?”Nature reviews drug discovery, vol. 19, no. 2, pp. 77–78, 2020

    work page 2020

  2. [2]

    Retrospective on establishing rare diseases medical service system and research platform in china,

    Z. Yicheng and S. Zhang, “Retrospective on establishing rare diseases medical service system and research platform in china,”Journal of Rare Diseases, pp. 93–96, 2022

    work page 2022

  3. [3]

    Dare to think rare: diagnostic delay and rare diseases,

    W. R. Evans, “Dare to think rare: diagnostic delay and rare diseases,” The British Journal of General Practice, vol. 68, no. 670, p. 224, 2018

    work page 2018

  4. [4]

    Epigenomic approaches for the diagnosis of rare diseases,

    B. Martinez-Delgado and M. J. Barrero, “Epigenomic approaches for the diagnosis of rare diseases,”Epigenomes, vol. 6, no. 3, p. 21, 2022

    work page 2022

  5. [5]

    A phenotype-based ai pipeline outperforms human experts in differentially diagnosing rare diseases using ehrs,

    X. Mao, Y . Huang, Y . Jin, L. Wang, X. Chen, H. Liuet al., “A phenotype-based ai pipeline outperforms human experts in differentially diagnosing rare diseases using ehrs,”npj Digital Medicine, vol. 8, no. 1, p. 68, 2025

    work page 2025

  6. [6]

    Phen2disease: a phenotype- driven model for disease and gene prioritization by bidirectional max- imum matching semantic similarities,

    W. Zhai, X. Huang, N. Shen, and S. Zhu, “Phen2disease: a phenotype- driven model for disease and gene prioritization by bidirectional max- imum matching semantic similarities,”Briefings in Bioinformatics, vol. 24, no. 4, p. bbad172, 2023

    work page 2023

  7. [7]

    Measuring phenotype semantic similarity using human phenotype ontology,

    J. Peng, H. Xue, Y . Shao, X. Shang, Y . Wang, and J. Chen, “Measuring phenotype semantic similarity using human phenotype ontology,” in 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2016, pp. 763–766

    work page 2016

  8. [8]

    Rare disease discovery: An optimized disease ranking system,

    M. Pinol, R. Alves, I. Teixido, J. Mateo, F. Solsona, and E. Vilapriny ´o, “Rare disease discovery: An optimized disease ranking system,”IEEE Transactions on Industrial Informatics, vol. 13, no. 3, pp. 1184–1192, 2017

    work page 2017

  9. [9]

    Phen2gene: rapid phenotype-driven gene prioritization for rare dis- eases,

    M. Zhao, J. M. Havrilla, L. Fang, Y . Chen, J. Peng, C. Liuet al., “Phen2gene: rapid phenotype-driven gene prioritization for rare dis- eases,”NAR genomics and Bioinformatics, vol. 2, no. 2, p. lqaa032, 2020

    work page 2020

  10. [10]

    Clinphen extracts and prioritizes patient phenotypes directly from medical records to expedite genetic disease diagnosis,

    C. A. Deisseroth, J. Birgmeier, E. E. Bodle, J. N. Kohler, D. R. Matalon, Y . Nazarenko, C. A. Genetti, C. A. Brownstein, K. Schmitz-Abe, K. Schochet al., “Clinphen extracts and prioritizes patient phenotypes directly from medical records to expedite genetic disease diagnosis,” Genetics in Medicine, vol. 21, no. 7, pp. 1585–1593, 2019

    work page 2019

  11. [11]

    Phenotype-driven strategies for exome prioritization of human mendelian disease genes,

    D. Smedley and P. N. Robinson, “Phenotype-driven strategies for exome prioritization of human mendelian disease genes,”Genome medicine, vol. 7, no. 1, p. 81, 2015

    work page 2015

  12. [12]

    arXiv preprint arXiv:2502.12671 , year=

    B. Wang, H. Zhao, H. Zhou, L. Song, M. Xu, W. Cheng, X. Zeng, Y . Zhang, Y . Huo, Z. Wanget al., “Baichuan-m1: Pushing the medical capability of large language models,”arXiv preprint arXiv:2502.12671, 2025

    work page arXiv 2025

  13. [13]

    Huatuo: Tuning llama model with chinese medical knowledge,

    H. Wang, C. Liu, N. Xi, Z. Qiang, S. Zhao, B. Qin, and T. Liu, “Huatuo: Tuning llama model with chinese medical knowledge,”arXiv preprint arXiv:2304.06975, 2023

    work page arXiv 2023

  14. [14]

    The human phenotype ontology in 2024: phenotypes around the world

    P. Talapova, M. Gargano, N. Matentzoglu, B. Coleman, E. Addo-Lartey, A. Anagnostopouloset al., “The human phenotype ontology in 2024: phenotypes around the world.” 2023

    work page 2024

  15. [15]

    Omim. org: Online mendelian inheritance in man (omim®), an online catalog of human genes and genetic disorders,

    J. S. Amberger, C. A. Bocchini, F. Schiettecatte, A. F. Scott, and A. Hamosh, “Omim. org: Online mendelian inheritance in man (omim®), an online catalog of human genes and genetic disorders,” Nucleic acids research, vol. 43, no. D1, pp. D789–D798, 2015

    work page 2015

  16. [16]

    Deepseek- r1 incentivizes reasoning in llms through reinforcement learning,

    D. Guo, D. Yang, H. Zhang, J. Song, P. Wang, Q. Zhuet al., “Deepseek- r1 incentivizes reasoning in llms through reinforcement learning,”Na- ture, vol. 645, no. 8081, pp. 633–638, 2025

    work page 2025

  17. [17]

    Gemini pro,

    Google DeepMind, “Gemini pro,” 2025, accessed: 2025-07-26. [Online]. Available: https://deepmind.google/models/gemini/pro/

    work page 2025

  18. [18]

    arXiv preprint arXiv:2402.00157 , year=

    J. Ahn, R. Verma, R. Lou, D. Liu, R. Zhang, and W. Yin, “Large lan- guage models for mathematical reasoning: Progresses and challenges,” arXiv preprint arXiv:2402.00157, 2024

    work page arXiv 2024

  19. [19]

    Integrating chain- of-thought and retrieval augmented generation enhances rare disease diagnosis from clinical notes,

    D. Wu, Z. Wang, Q. Nguyen, and K. Wang, “Integrating chain- of-thought and retrieval augmented generation enhances rare disease diagnosis from clinical notes,” 2025. [Online]. Available: https: //arxiv.org/abs/2503.12286

    work page arXiv 2025

  20. [20]

    Rareagents: Advancing rare disease care through llm-empowered multi-disciplinary team.arXiv preprint arXiv:2412.12475, 2024

    X. Chen, Y . Jin, X. Mao, L. Wang, S. Zhang, and T. Chen, “Rareagents: Advancing rare disease care through llm-empowered multi-disciplinary team,” 2025. [Online]. Available: https://arxiv.org/abs/2412.12475

    work page arXiv 2025

  21. [21]

    An agentic system for rare disease diagnosis with traceable reasoning,

    W. Zhao, C. Wu, Y . Fan, X. Zhang, P. Qiu, Y . Sunet al., “An agentic system for rare disease diagnosis with traceable reasoning,” arXiv preprint arXiv:2506.20430, 2025

    work page arXiv 2025

  22. [22]

    DeepSeekMath: Pushing the Limits of Mathematical Reasoning in Open Language Models

    Z. Shao, P. Wang, Q. Zhu, R. Xu, J. Song, X. Bi, H. Zhang, M. Zhang, Y . K. Li, Y . Wu, and D. Guo, “Deepseekmath: Pushing the limits of mathematical reasoning in open language models,” 2024. [Online]. Available: https://arxiv.org/abs/2402.03300

    work page internal anchor Pith review Pith/arXiv arXiv 2024

  23. [23]

    DAPO: An Open-Source LLM Reinforcement Learning System at Scale

    Q. Yu, Z. Zhang, R. Zhu, Y . Yuan, X. Zuo, Y . Yueet al., “Dapo: An open-source llm reinforcement learning system at scale,” 2025. [Online]. Available: https://arxiv.org/abs/2503.14476

    work page internal anchor Pith review Pith/arXiv arXiv 2025

  24. [24]

    arXiv preprint arXiv:2503.13939 , year=

    Y . Lai, J. Zhong, M. Li, S. Zhao, and X. Yang, “Med-r1: Reinforcement learning for generalizable medical reasoning in vision-language models,” 2025. [Online]. Available: https://arxiv.org/abs/2503.13939

    work page arXiv 2025

  25. [25]

    arXiv preprint arXiv:2502.19655 , year=

    S. Zhang, Q. Liu, G. Qin, T. Naumann, and H. Poon, “Med-rlvr: Emerging medical reasoning from a 3b base model via reinforcement learning,” 2025. [Online]. Available: https://arxiv.org/abs/2502.19655

    work page arXiv 2025

  26. [26]

    Orphanet: a european database for rare diseases,

    S. S. Weinreich, R. Mangon, J. Sikkens, M. E. Teeuw, and M. Cornel, “Orphanet: a european database for rare diseases,”Nederlands tijdschrift voor geneeskunde, vol. 152, no. 9, pp. 518–519, 2008

    work page 2008

  27. [27]

    W. H. Organization,The ICD-10 classification of mental and be- havioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, 1992, vol. 1

    work page 1992

  28. [28]

    Pubmed: the bibliographic database,

    K. Canese and S. Weis, “Pubmed: the bibliographic database,”The NCBI handbook, vol. 2, no. 1, 2013

    work page 2013

  29. [29]

    Rarearena,

    “Rarearena,” https://github.com/zhao-zy15/RareArena, 2024, accessed: 2025-05-01

    work page 2024

  30. [30]

    Mimic-iv, a freely accessible electronic health record dataset,

    A. E. Johnson, L. Bulgarelli, L. Shen, A. Gayles, A. Shammout, S. Hornget al., “Mimic-iv, a freely accessible electronic health record dataset,”Scientific data, vol. 10, no. 1, p. 1, 2023

    work page 2023

  31. [31]

    Qwen3 Technical Report

    A. Yang, A. Li, B. Yang, B. Zhang, B. Hui, B. Zheng, B. Yu, C. Gao, C. Huang, C. Lvet al., “Qwen3 technical report,”arXiv preprint arXiv:2505.09388, 2025

    work page internal anchor Pith review Pith/arXiv arXiv 2025

  32. [32]

    Diagnosis- arena: Benchmarking diagnostic reasoning for large language models,

    Y . Zhu, Z. Huang, L. Mu, Y . Huang, W. Nie, J. Liuet al., “Diagnosis- arena: Benchmarking diagnostic reasoning for large language models,” arXiv preprint arXiv:2505.14107, 2025

    work page arXiv 2025

  33. [33]

    Rarebench: can llms serve as rare diseases specialists?

    X. Chen, X. Mao, Q. Guo, L. Wang, S. Zhang, and T. Chen, “Rarebench: can llms serve as rare diseases specialists?” inProceedings of the 30th ACM SIGKDD conference on knowledge discovery and data mining, 2024, pp. 4850–4861

    work page 2024

  34. [34]

    GPT-4 Technical Report

    J. Achiam, S. Adler, S. Agarwal, L. Ahmad, I. Akkaya, F. L. Aleman, D. Almeida, J. Altenschmidt, S. Altman, S. Anadkatet al., “Gpt-4 technical report,”arXiv preprint arXiv:2303.08774, 2023

    work page internal anchor Pith review Pith/arXiv arXiv 2023

  35. [35]

    HuatuoGPT-o1, Towards Medical Complex Reasoning with LLMs

    J. Chen, Z. Cai, K. Ji, X. Wang, W. Liu, R. Wanget al., “Huatuogpt- o1, towards medical complex reasoning with llms,”arXiv preprint arXiv:2412.18925, 2024

    work page internal anchor Pith review Pith/arXiv arXiv 2024